Intravenous Iron Drugs Market Overview The Intravenous Iron Drugs Market was valued at $2.79 billion in 2023 and is projected to grow at a CAGR of 8.5% from 2024 to 2030, reaching approximately $4.95 billion by 2030. This market primarily addresses iron deficiency, a significant contributor to iron deficiency anemia (IDA), which affects millions globally, particularly women and...